(Q53400243)
Statements
Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study. (English)
Kelly JP
Shapiro S
1 March 1991
49
3
330-341